Article
Mood congruent psychotic symptoms and specific cognitive deficits in carriers of the novel schizophrenia risk variant at MIR-137.
Neuroscience letters - 4 Jan 2013
Cummings E, Donohoe G, Hargreaves A, Moore S, Fahey C, Dinan T G, McDonald C, O'Callaghan E, O'Neill F A, Waddington J L, Murphy K C, Morris D W, Gill M, Corvin A
Abstract excerpt
OBJECTIVE: The Schizophrenia Psychiatric Genome-wide Association (GWAS) Consortium recently reported on five novel schizophrenia susceptibility loci. The most significant finding mapped to a micro-RNA, MIR-137, which may be involved in regulating the function of other schizophrenia and bipolar disorder susceptibility genes. METHOD: We genotyped 821 patients with confirmed DSM-IV diagnoses of schizophrenia,...
Topics
Join the communities discussing this publication.